Sociodemographic and survival disparities for histologic variants of bladder cancer

Joshua S. Jue, Tulay Sengul, Kevin J. Moore, Feng Miao, Mahmoud Alameddine, Bruno Nahar, Sanoj Punnen, Dipen J Parekh, Chad Ritch, Mark L Gonzalgo

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Introduction: To investigate the impact of perioperative factors on overall survival among patients with histologic variants of bladder cancer treated with radical cystectomy. Materials and methods: The National Cancer Data Base was utilized to identify patients diagnosed with muscleinvasive bladder cancer (cT2-4, N0, M0) from 2004-2013. Variant histology bladder cancers (non-mucinous adenocarcinoma, mucinous/signet ring adenocarcinoma, micropapillary urothelial carcinoma, small cell carcinoma, and squamous cell carcinoma) were compared to urothelial carcinoma with respect to overall survival. Adjusted hazard ratios (aHR) and 95% confidence intervals (95% CI) were calculated from a multivariable Cox regression model to examine factors affecting overall survival, T upstaging, N upstaging, and positive surgical margins. Median survival was calculated using Kaplan-Meier analysis. Results: A total of 5,856 patients were included in this study. Significant predictors of worse overall survival included: African-American ancestry (aHR = 1.24, 95%CI: 1.03-1.48, p = 0.021), age (1.03, 1.02-1.03, p < 0.001), comorbidity (1.30, 1.20-1.40, p < 0.001), cT3 stage (1.41, 1.26-1.57, p < 0.001), and cT4 stage (1.59, 1.38-1.84, p < 0.001). Small cell carcinoma (2.10, 1.44-3.06, p < 0.001) and nonmucinous adenocarcinoma (1.59, 1.15-2.20, p = 0.005) were significant predictors of worse overall survival compared to urothelial carcinoma. Small cell carcinoma had the worst 5 year overall survival (15.5%, 95% CI: 5.2%-30.9%) compared to urothelial carcinoma (48.7%, 95% CI: 47.2%-50.2%). Micropapillary urothelial carcinoma was a significant predictor of increased progression to node positivity and positive margin status after radical cystectomy compared to urothelial carcinoma (6.01, 3.11-11.63, p < 0.001; 4.38, 2.05-9.38; p < 0.001). Conclusions: Among bladder cancer patients with equal treatment and staging, small cell carcinoma and non-mucinous adenocarcinoma variant histologies were predictive of worse overall survival compared to urothelial carcinoma. Patient demographics such as African- American ancestry and age were also predictive of worse overall survival among variant histology bladder cancer and urothelial carcinoma.

Original languageEnglish (US)
Pages (from-to)9179-9185
Number of pages7
JournalCanadian Journal of Urology
Volume25
Issue number1
StatePublished - Feb 1 2018

Fingerprint

Urinary Bladder Neoplasms
Carcinoma
Survival
Small Cell Carcinoma
Histology
Adenocarcinoma
Cystectomy
Confidence Intervals
African Americans
Mucinous Adenocarcinoma
Kaplan-Meier Estimate
Proportional Hazards Models
Comorbidity
Squamous Cell Carcinoma
Demography
Databases

Keywords

  • Bladder cancer
  • Histologic variants
  • Histology
  • National Cancer Data Base
  • NCDB
  • Sociodemographic disparities

ASJC Scopus subject areas

  • Urology

Cite this

Sociodemographic and survival disparities for histologic variants of bladder cancer. / Jue, Joshua S.; Sengul, Tulay; Moore, Kevin J.; Miao, Feng; Alameddine, Mahmoud; Nahar, Bruno; Punnen, Sanoj; Parekh, Dipen J; Ritch, Chad; Gonzalgo, Mark L.

In: Canadian Journal of Urology, Vol. 25, No. 1, 01.02.2018, p. 9179-9185.

Research output: Contribution to journalArticle

Jue JS, Sengul T, Moore KJ, Miao F, Alameddine M, Nahar B et al. Sociodemographic and survival disparities for histologic variants of bladder cancer. Canadian Journal of Urology. 2018 Feb 1;25(1):9179-9185.
Jue, Joshua S. ; Sengul, Tulay ; Moore, Kevin J. ; Miao, Feng ; Alameddine, Mahmoud ; Nahar, Bruno ; Punnen, Sanoj ; Parekh, Dipen J ; Ritch, Chad ; Gonzalgo, Mark L. / Sociodemographic and survival disparities for histologic variants of bladder cancer. In: Canadian Journal of Urology. 2018 ; Vol. 25, No. 1. pp. 9179-9185.
@article{7533469f4f794f0bbcde96c991524b2e,
title = "Sociodemographic and survival disparities for histologic variants of bladder cancer",
abstract = "Introduction: To investigate the impact of perioperative factors on overall survival among patients with histologic variants of bladder cancer treated with radical cystectomy. Materials and methods: The National Cancer Data Base was utilized to identify patients diagnosed with muscleinvasive bladder cancer (cT2-4, N0, M0) from 2004-2013. Variant histology bladder cancers (non-mucinous adenocarcinoma, mucinous/signet ring adenocarcinoma, micropapillary urothelial carcinoma, small cell carcinoma, and squamous cell carcinoma) were compared to urothelial carcinoma with respect to overall survival. Adjusted hazard ratios (aHR) and 95{\%} confidence intervals (95{\%} CI) were calculated from a multivariable Cox regression model to examine factors affecting overall survival, T upstaging, N upstaging, and positive surgical margins. Median survival was calculated using Kaplan-Meier analysis. Results: A total of 5,856 patients were included in this study. Significant predictors of worse overall survival included: African-American ancestry (aHR = 1.24, 95{\%}CI: 1.03-1.48, p = 0.021), age (1.03, 1.02-1.03, p < 0.001), comorbidity (1.30, 1.20-1.40, p < 0.001), cT3 stage (1.41, 1.26-1.57, p < 0.001), and cT4 stage (1.59, 1.38-1.84, p < 0.001). Small cell carcinoma (2.10, 1.44-3.06, p < 0.001) and nonmucinous adenocarcinoma (1.59, 1.15-2.20, p = 0.005) were significant predictors of worse overall survival compared to urothelial carcinoma. Small cell carcinoma had the worst 5 year overall survival (15.5{\%}, 95{\%} CI: 5.2{\%}-30.9{\%}) compared to urothelial carcinoma (48.7{\%}, 95{\%} CI: 47.2{\%}-50.2{\%}). Micropapillary urothelial carcinoma was a significant predictor of increased progression to node positivity and positive margin status after radical cystectomy compared to urothelial carcinoma (6.01, 3.11-11.63, p < 0.001; 4.38, 2.05-9.38; p < 0.001). Conclusions: Among bladder cancer patients with equal treatment and staging, small cell carcinoma and non-mucinous adenocarcinoma variant histologies were predictive of worse overall survival compared to urothelial carcinoma. Patient demographics such as African- American ancestry and age were also predictive of worse overall survival among variant histology bladder cancer and urothelial carcinoma.",
keywords = "Bladder cancer, Histologic variants, Histology, National Cancer Data Base, NCDB, Sociodemographic disparities",
author = "Jue, {Joshua S.} and Tulay Sengul and Moore, {Kevin J.} and Feng Miao and Mahmoud Alameddine and Bruno Nahar and Sanoj Punnen and Parekh, {Dipen J} and Chad Ritch and Gonzalgo, {Mark L}",
year = "2018",
month = "2",
day = "1",
language = "English (US)",
volume = "25",
pages = "9179--9185",
journal = "The Canadian journal of urology",
issn = "1195-9479",
publisher = "Canadian Journal of Urology",
number = "1",

}

TY - JOUR

T1 - Sociodemographic and survival disparities for histologic variants of bladder cancer

AU - Jue, Joshua S.

AU - Sengul, Tulay

AU - Moore, Kevin J.

AU - Miao, Feng

AU - Alameddine, Mahmoud

AU - Nahar, Bruno

AU - Punnen, Sanoj

AU - Parekh, Dipen J

AU - Ritch, Chad

AU - Gonzalgo, Mark L

PY - 2018/2/1

Y1 - 2018/2/1

N2 - Introduction: To investigate the impact of perioperative factors on overall survival among patients with histologic variants of bladder cancer treated with radical cystectomy. Materials and methods: The National Cancer Data Base was utilized to identify patients diagnosed with muscleinvasive bladder cancer (cT2-4, N0, M0) from 2004-2013. Variant histology bladder cancers (non-mucinous adenocarcinoma, mucinous/signet ring adenocarcinoma, micropapillary urothelial carcinoma, small cell carcinoma, and squamous cell carcinoma) were compared to urothelial carcinoma with respect to overall survival. Adjusted hazard ratios (aHR) and 95% confidence intervals (95% CI) were calculated from a multivariable Cox regression model to examine factors affecting overall survival, T upstaging, N upstaging, and positive surgical margins. Median survival was calculated using Kaplan-Meier analysis. Results: A total of 5,856 patients were included in this study. Significant predictors of worse overall survival included: African-American ancestry (aHR = 1.24, 95%CI: 1.03-1.48, p = 0.021), age (1.03, 1.02-1.03, p < 0.001), comorbidity (1.30, 1.20-1.40, p < 0.001), cT3 stage (1.41, 1.26-1.57, p < 0.001), and cT4 stage (1.59, 1.38-1.84, p < 0.001). Small cell carcinoma (2.10, 1.44-3.06, p < 0.001) and nonmucinous adenocarcinoma (1.59, 1.15-2.20, p = 0.005) were significant predictors of worse overall survival compared to urothelial carcinoma. Small cell carcinoma had the worst 5 year overall survival (15.5%, 95% CI: 5.2%-30.9%) compared to urothelial carcinoma (48.7%, 95% CI: 47.2%-50.2%). Micropapillary urothelial carcinoma was a significant predictor of increased progression to node positivity and positive margin status after radical cystectomy compared to urothelial carcinoma (6.01, 3.11-11.63, p < 0.001; 4.38, 2.05-9.38; p < 0.001). Conclusions: Among bladder cancer patients with equal treatment and staging, small cell carcinoma and non-mucinous adenocarcinoma variant histologies were predictive of worse overall survival compared to urothelial carcinoma. Patient demographics such as African- American ancestry and age were also predictive of worse overall survival among variant histology bladder cancer and urothelial carcinoma.

AB - Introduction: To investigate the impact of perioperative factors on overall survival among patients with histologic variants of bladder cancer treated with radical cystectomy. Materials and methods: The National Cancer Data Base was utilized to identify patients diagnosed with muscleinvasive bladder cancer (cT2-4, N0, M0) from 2004-2013. Variant histology bladder cancers (non-mucinous adenocarcinoma, mucinous/signet ring adenocarcinoma, micropapillary urothelial carcinoma, small cell carcinoma, and squamous cell carcinoma) were compared to urothelial carcinoma with respect to overall survival. Adjusted hazard ratios (aHR) and 95% confidence intervals (95% CI) were calculated from a multivariable Cox regression model to examine factors affecting overall survival, T upstaging, N upstaging, and positive surgical margins. Median survival was calculated using Kaplan-Meier analysis. Results: A total of 5,856 patients were included in this study. Significant predictors of worse overall survival included: African-American ancestry (aHR = 1.24, 95%CI: 1.03-1.48, p = 0.021), age (1.03, 1.02-1.03, p < 0.001), comorbidity (1.30, 1.20-1.40, p < 0.001), cT3 stage (1.41, 1.26-1.57, p < 0.001), and cT4 stage (1.59, 1.38-1.84, p < 0.001). Small cell carcinoma (2.10, 1.44-3.06, p < 0.001) and nonmucinous adenocarcinoma (1.59, 1.15-2.20, p = 0.005) were significant predictors of worse overall survival compared to urothelial carcinoma. Small cell carcinoma had the worst 5 year overall survival (15.5%, 95% CI: 5.2%-30.9%) compared to urothelial carcinoma (48.7%, 95% CI: 47.2%-50.2%). Micropapillary urothelial carcinoma was a significant predictor of increased progression to node positivity and positive margin status after radical cystectomy compared to urothelial carcinoma (6.01, 3.11-11.63, p < 0.001; 4.38, 2.05-9.38; p < 0.001). Conclusions: Among bladder cancer patients with equal treatment and staging, small cell carcinoma and non-mucinous adenocarcinoma variant histologies were predictive of worse overall survival compared to urothelial carcinoma. Patient demographics such as African- American ancestry and age were also predictive of worse overall survival among variant histology bladder cancer and urothelial carcinoma.

KW - Bladder cancer

KW - Histologic variants

KW - Histology

KW - National Cancer Data Base

KW - NCDB

KW - Sociodemographic disparities

UR - http://www.scopus.com/inward/record.url?scp=85043473833&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85043473833&partnerID=8YFLogxK

M3 - Article

VL - 25

SP - 9179

EP - 9185

JO - The Canadian journal of urology

JF - The Canadian journal of urology

SN - 1195-9479

IS - 1

ER -